iCAD, INC. (NASDAQ:ICAD)

CAPS Rating: 5 out of 5

The Company designs, develops, manufactures and markets Computer-Aided Detection solutions that enable healthcare professionals to serve patients by identifying pathologies and pinpointing cancer earlier.

Recs

0
Player Avatar Tr0n (< 20) Submitted: 5/2/2008 12:33:19 PM : Outperform Start Price: $3.30 ICAD Score: -82.45

Decent growth prospects.

Featured Broker Partners


Advertisement